Martine Zimmermann
Director/Board Member bij INVENTIVA
Vermogen: 160 795 $ op 30-04-2024
Actieve functies van Martine Zimmermann
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INVENTIVA | Director/Board Member | 16-04-2021 | - |
| Independent Dir/Board Member | 16-04-2021 | - | |
| LIGAND PHARMACEUTICALS INCORPORATED | Director/Board Member | 26-09-2023 | - |
| Independent Dir/Board Member | 26-09-2023 | - | |
| Ipsen Biopharmaceuticals, Inc. | General Counsel | - | - |
Loopbaan van Martine Zimmermann
Eerdere bekende functies van Martine Zimmermann
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | General Counsel | 01-06-2016 | 01-02-2023 |
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Director/Board Member | 01-03-2019 | 01-01-2021 |
Opleiding van Martine Zimmermann
| University of Strasbourg | Doctorate Degree |
| Louis Pasteur University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Frankrijk | 4 |
Operationeel
| Director/Board Member | 3 |
| Independent Dir/Board Member | 2 |
| General Counsel | 2 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| INVENTIVA | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
| Ipsen Biopharmaceuticals, Inc. | |
Caelum Biosciences, Inc.
Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Health Technology |
- Beurs
- Insiders
- Martine Zimmermann
- Ervaring
